A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Elvitegravir Impurity 14 - Request Quote

Picture of Elvitegravir Impurity 14

Elvitegravir Impurity 14

SZ CAT No:SZ-E078032
CAS No
NA
Mol.F.
C20H20F2O5
Mol.Wt.
378.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Elvitegravir Impurity 14 is chemically Ethyl 3-(5-(2,3-difluorobenzyl)-2,4-dimethoxyphenyl)-3-oxopropanoate. Elvitegravir Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Elvitegravir Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Elvitegravir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Elvitegravir Impurity 14

Purchase Elvitegravir Impurity 14

Elvitegravir Impurity 14 suppliers

Elvitegravir Impurity 14 manufacturers

Elvitegravir Impurity 14 price

Order Elvitegravir Impurity 14

Enquire Elvitegravir Impurity 14

Elvitegravir Impurity 14 cost

Elvitegravir Impurity 14 Supplier

Elvitegravir Impurity 14 Distributor

Elvitegravir Impurity 14 for Method Validation

Elvitegravir Reference Standard

Elvitegravir Impurity 14 for ANDA Filing

Elvitegravir Impurity 14 for Forced Degradation Studies

Elvitegravir Impurity 14 Identification Standards

Elvitegravir Impurity 14 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,